Last update:
Parkinson's & Movement disorders
While much attention has focused on the potential for severe respiratory complications and unfavorable outcomes from the COVID-19 pandemic among patients with Parkinson's disease (PD), the impact extends beyond these threats. ...
Apr 03, 2020
1
106
Psychology & Psychiatry
Telephone-based cognitive behavioral therapy (T-CBT) seems to be an effective intervention for depression in Parkinson disease (PD), outperforming treatment-as-usual (TAU) on all depression, anxiety, and quality-of-life measures, ...
Apr 02, 2020
0
2
People with Parkinson's disease who engage in cognitive behavioral therapy—a form of psychotherapy that increases awareness of negative thinking and teaches coping skills—are more likely to overcome depression and anxiety, ...
Apr 01, 2020
0
61
Long-term treatment with immediate-release isradipine does not seem to slow the clinical progression of early-stage Parkinson's disease. Findings from a multicenter, randomized, parallel-group, double-blind, placebo-controlled ...
Mar 31, 2020
0
0
The new coronavirus poses a significant risk to people with Parkinson's disease, and experts say they and their caregivers need to take precautions.
Mar 25, 2020
0
3
Scientists have discovered a possible link between Parkinson's disease and a gene impacted by a neurotoxin found in blue-green algae.
Mar 16, 2020
0
165
Researchers at the University of Georgia's Regenerative Bioscience Center and their colleagues have found that "natural killer" white blood cells could guard against the cascade of cellular changes that lead to Parkinson's ...
Mar 13, 2020
0
139
A new book titled "Ending Parkinson's Disease: A Prescription for Action" and authored by University of Rochester Medical Center neurologist Ray Dorsey, M.D. and his colleagues, lays out a new vision to prevent, advocate ...
Mar 12, 2020
0
5
Vision and eye problems like blurry vision, dry eyes, trouble with depth perception, and problems adjusting to rapid changes in light are much more common in people with Parkinson's disease than in people without the disorder, ...
Mar 11, 2020
0
61
A master control region of a protein linked to Parkinson's disease has been identified for the first time.
Mar 09, 2020
0
108
A huge step forward has been made in understanding the multiple ways Parkinson's Disease can develop; the findings of which could be a crucial catalyst to discover new personalized drug treatments.
Mar 04, 2020
0
18
People with Parkinson's disease who participate in a special, non-contact boxing program may have better quality of life and be more likely to exercise than those who do not participate, according to a preliminary study released ...
Mar 04, 2020
0
29
Results from a study looking at an experimental drug to tackle the debilitating side effect of dyskinesia, have offered hope that it may have potential as a future treatment for people with Parkinson's.
Mar 02, 2020
0
11
Parkinson's disease researchers have used gene-editing tools to introduce the disorder's most common genetic mutation into marmoset monkey stem cells and to successfully tamp down cellular chemistry that often goes awry in ...
Feb 27, 2020
0
8
Pingpong may hold promise as a possible form of physical therapy for Parkinson's disease. People with Parkinson's who participated in a pingpong exercise program once a week for six months showed improvement in their Parkinson's ...
Feb 25, 2020
0
13
In a breakthrough for Parkinson's disease, scientists at EPFL have reconstructed the process by which Lewy bodies form in the brain of patients. The study offers new insights into how Parkinson's disease begins and evolves, ...
Feb 20, 2020
0
169
A cutting-edge MRI technique to detect iron deposits in different brain regions can track declines in thinking, memory and movement in people with Parkinson's disease, finds a new UCL-led study.
Feb 20, 2020
0
329
Parkinson's disease (PD) is a debilitating neurodegenerative disorder, impairing the motor functions of millions of elderly people worldwide. Often, people with PD will experience disturbances in gastrointestinal function, ...
Feb 18, 2020
1
292
The top contributor to familial Parkinson's disease is mutations in leucine-rich repeat kinase 2 (LRRK2), whose large and difficult structure has finally been solved, paving the way for targeted therapies. University of California, ...
Feb 18, 2020
0
3
A promising molecule has offered hope for a new treatment that could stop or slow Parkinson's, something no treatment can currently do.
Feb 14, 2020
0
8
